Ecolab (ECL) Appoints Eric Green to Board of Directors

Get Alerts ECL Hot Sheet
Overall Analyst Rating:
NEUTRAL (= Flat)
Dividend Yield: 0.4%
Revenue Growth %: +10.6%
Join SI Premium – FREE
Get inside Wall Street with StreetInsider Premium. Claim your 1-week free trial here.
The board of directors of Ecolab Inc. has appointed Eric Green to the Ecolab board, effective December 8, 2022. Mr. Green will serve as an independent director and a member of the Compensation and Human Capital Management Committee and the Governance Committee.
“Eric is an accomplished executive with decades of experience in the life sciences industry. He is joining a strong Board that is focused on delivering growth for all Ecolab stakeholders,” said Christophe Beck, Ecolab chairman and chief executive officer.
“At Ecolab, we regularly review and refresh the Board’s composition to ensure we are best positioned to effectively oversee the execution of our growth strategy. Consistent with Ecolab’s other recent appointments, Eric will bring new insights, global operating experience and public company leadership expertise to the Board,” said Jeffrey Ettinger, lead independent director for the Ecolab board.
“Ecolab is an impressive company and I am honored to join this accomplished Board at such an important time in its history,” said Mr. Green. “I have followed Ecolab’s success for many years and look forward to collaborating with the entire Board and management team to capitalize on the many opportunities ahead to deliver sustainable long-term growth and value for shareholders.”
Mr. Green, age 53, is a seasoned executive with nearly 30 years of life sciences experience with a proven track record of driving growth and creating value. Mr. Green currently serves as Chairman, President and Chief Executive Officer of West Pharmaceutical Services Inc., a manufacturer of packaging components and delivery systems for injectable drugs and healthcare products. Prior to joining West Pharmaceutical Services, Mr. Green spent more than 20 years in a variety of leadership positions at Sigma-Aldrich Corporation, including as Executive Vice President and President, Research Markets BU. Mr. Green currently serves on the Boards of West Pharmaceutical Services and the Board of Trustees at Bethel University.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Safe & Green (SGBX) Chairman and CEO Releases Letter to Shareholders
- PyroGenesis Canada (PYR) Provides Update on the PUREVAP QRR Project with HPQ Silicon
- Virax Biolabs Group (VRAX) CEO Issues Letter to Shareholders
Create E-mail Alert Related Categories
Board Changes, Corporate NewsRelated Entities
TwitterSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!